Your browser doesn't support javascript.
loading
SMIM1 underlies the Vel blood group and influences red blood cell traits.
Cvejic, Ana; Haer-Wigman, Lonneke; Stephens, Jonathan C; Kostadima, Myrto; Smethurst, Peter A; Frontini, Mattia; van den Akker, Emile; Bertone, Paul; Bielczyk-Maczynska, Ewa; Farrow, Samantha; Fehrmann, Rudolf Sn; Gray, Alan; de Haas, Masja; Haver, Vincent G; Jordan, Gregory; Karjalainen, Juha; Kerstens, Hindrik Hd; Kiddle, Graham; Lloyd-Jones, Heather; Needs, Malcolm; Poole, Joyce; Soussan, Aicha Ait; Rendon, Augusto; Rieneck, Klaus; Sambrook, Jennifer G; Schepers, Hein; Silljé, Herman H W; Sipos, Botond; Swinkels, Dorine; Tamuri, Asif U; Verweij, Niek; Watkins, Nicholas A; Westra, Harm-Jan; Stemple, Derek; Franke, Lude; Soranzo, Nicole; Stunnenberg, Hendrik G; Goldman, Nick; van der Harst, Pim; van der Schoot, C Ellen; Ouwehand, Willem H; Albers, Cornelis A.
Affiliation
  • Cvejic A; Department of Haematology, University of Cambridge, CB2 0PT, United Kingdom.
  • Haer-Wigman L; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1HH, United Kingdom.
  • Stephens JC; Department of Experimental Immunohaematology, Sanquin Research, 1066 CX, Amsterdam, The Netherlands.
  • Kostadima M; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, 1066 CX, The Netherlands.
  • Smethurst PA; Department of Haematology, University of Cambridge, CB2 0PT, United Kingdom.
  • Frontini M; NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, United Kingdom.
  • van den Akker E; NHS Blood and Transplant, Cambridge, CB2 0PT, United Kingdom.
  • Bertone P; EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom.
  • Bielczyk-Maczynska E; Department of Haematology, University of Cambridge, CB2 0PT, United Kingdom.
  • Farrow S; NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, United Kingdom.
  • Fehrmann RS; NHS Blood and Transplant, Cambridge, CB2 0PT, United Kingdom.
  • Gray A; Department of Haematology, University of Cambridge, CB2 0PT, United Kingdom.
  • de Haas M; NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, United Kingdom.
  • Haver VG; NHS Blood and Transplant, Cambridge, CB2 0PT, United Kingdom.
  • Jordan G; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, 1066 CX, The Netherlands.
  • Karjalainen J; Department of Hematopoiesis, Sanquin Research, Amsterdam, 1066 CX, The Netherlands.
  • Kerstens HH; EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom.
  • Kiddle G; Department of Haematology, University of Cambridge, CB2 0PT, United Kingdom.
  • Lloyd-Jones H; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1HH, United Kingdom.
  • Needs M; NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, United Kingdom.
  • Poole J; NHS Blood and Transplant, Cambridge, CB2 0PT, United Kingdom.
  • Soussan AA; Department of Haematology, University of Cambridge, CB2 0PT, United Kingdom.
  • Rendon A; NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, United Kingdom.
  • Rieneck K; NHS Blood and Transplant, Cambridge, CB2 0PT, United Kingdom.
  • Sambrook JG; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, 9700 RB, The Netherlands.
  • Schepers H; NHS Blood and Transplant, Tooting, London, SW17 0RB, United Kingdom.
  • Silljé HHW; Department of Experimental Immunohaematology, Sanquin Research, 1066 CX, Amsterdam, The Netherlands.
  • Sipos B; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, 1066 CX, The Netherlands.
  • Swinkels D; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, 9700 RB, The Netherlands.
  • Tamuri AU; Somerville, Massachusetts, USA.
  • Verweij N; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, 9700 RB, The Netherlands.
  • Watkins NA; Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University, Nijmegen, 6525 GA, The Netherlands.
  • Westra HJ; Department of Haematology, University of Cambridge, CB2 0PT, United Kingdom.
  • Stemple D; NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, United Kingdom.
  • Franke L; NHS Blood and Transplant, Cambridge, CB2 0PT, United Kingdom.
  • Soranzo N; Department of Haematology, University of Cambridge, CB2 0PT, United Kingdom.
  • Stunnenberg HG; NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, United Kingdom.
  • Goldman N; NHS Blood and Transplant, Cambridge, CB2 0PT, United Kingdom.
  • van der Harst P; NHS Blood and Transplant, Tooting, London, SW17 0RB, United Kingdom.
  • van der Schoot CE; International Blood Group Reference Laboratory, NHS Blood and Transplant, North Bristol Park, Northway, Filton, Bristol, BS34 7QH, United Kingdom.
  • Ouwehand WH; Department of Experimental Immunohaematology, Sanquin Research, 1066 CX, Amsterdam, The Netherlands.
  • Albers CA; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, 1066 CX, The Netherlands.
Nat Genet ; 45(5): 542-545, 2013 May.
Article in En | MEDLINE | ID: mdl-23563608
The blood group Vel was discovered 60 years ago, but the underlying gene is unknown. Individuals negative for the Vel antigen are rare and are required for the safe transfusion of patients with antibodies to Vel. To identify the responsible gene, we sequenced the exomes of five individuals negative for the Vel antigen and found that four were homozygous and one was heterozygous for a low-frequency 17-nucleotide frameshift deletion in the gene encoding the 78-amino-acid transmembrane protein SMIM1. A follow-up study showing that 59 of 64 Vel-negative individuals were homozygous for the same deletion and expression of the Vel antigen on SMIM1-transfected cells confirm SMIM1 as the gene underlying the Vel blood group. An expression quantitative trait locus (eQTL), the common SNP rs1175550 contributes to variable expression of the Vel antigen (P = 0.003) and influences the mean hemoglobin concentration of red blood cells (RBCs; P = 8.6 × 10(-15)). In vivo, zebrafish with smim1 knockdown showed a mild reduction in the number of RBCs, identifying SMIM1 as a new regulator of RBC formation. Our findings are of immediate relevance, as the homozygous presence of the deletion allows the unequivocal identification of Vel-negative blood donors.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Group Antigens / Gene Deletion / Quantitative Trait Loci / Erythrocyte Membrane / Erythrocytes / Homozygote / Membrane Proteins Type of study: Observational_studies / Prognostic_studies Limits: Animals / Female / Humans / Pregnancy Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Group Antigens / Gene Deletion / Quantitative Trait Loci / Erythrocyte Membrane / Erythrocytes / Homozygote / Membrane Proteins Type of study: Observational_studies / Prognostic_studies Limits: Animals / Female / Humans / Pregnancy Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: United States